0
13

In This Issue
  |  
The American Journal of Psychiatry

February 01, 1999, Vol. 156, No. 2
Get Alert | RSS  
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

Editorial
Research in Affective Disorders Comes of Age
DAVID J. KUPFER, M.D.
Special Article
Sympathoadrenal Hyperactivity and the Etiology of Neuroleptic Malignant Syndrome
Ronald J. Gurrera, M.D.
Regular Article
Toward a Clinical Model of Suicidal Behavior in Psychiatric Patients
J. John Mann, M.D.; Christine Waternaux, Ph.D.; Gretchen L. Haas, Ph.D.; Kevin M. Malone, M.D.
Inadequacy of Antidepressant Treatment for Patients With Major Depression Who Are at Risk for Suicidal Behavior
Maria A. Oquendo, M.D.; Kevin M. Malone, M.D.; Steven P. Ellis, Ph.D.; Harold A. Sackeim, Ph.D.; J. John Mann, M.D.
Prospective Study of Fluoxetine Treatment and Suicidal Behavior in Affectively Ill Subjects
Andrew C. Leon, Ph.D.; Martin B. Keller, M.D.; Meredith G. Warshaw, M.S.S., M.A.; Timothy I. Mueller, M.D.; David A. Solomon, M.D.; William Coryell, M.D.; Jean Endicott, Ph.D.
Treatment of Bereavement-Related Major Depressive Episodes in Later Life: A Controlled Study of Acute and Continuation Treatment With Nortriptyline and Interpersonal Psychotherapy
Charles F. Reynolds, III, M.D.; Mark D. Miller, M.D.; Rona E. Pasternak, M.D.; Ellen Frank, Ph.D.; James M. Perel, Ph.D.; Cleon Cornes, M.D.; Patricia R. Houck, M.S.H.; Sati Mazumdar, Ph.D.; Mary Amanda Dew, Ph.D.; David J. Kupfer, M.D.
Functional MRI Study of the Cognitive Generation of Affect
John D. Teasdale, Ph.D.; Robert J. Howard, M.D.; Sally G. Cox, B.Sc.; Yvonne Ha, M.B., B.S.; Michael J. Brammer, Ph.D.; Steven C.R. Williams, Ph.D.; Stuart A. Checkley, M.D.
Amygdalar Volume and Emotional Memory in Alzheimer’s Disease
Etsuro Mori, M.D., Ph.D.; Manabu Ikeda, M.D., Ph.D.; Nobutsugu Hirono, M.D., Ph.D.; Hajime Kitagaki, M.D., Ph.D.; Toru Imamura, M.D.; Tatsuo Shimomura, M.D.
Caffeine Intake, Tolerance, and Withdrawal in Women: A Population-Based Twin Study
Kenneth S. Kendler, M.D.; Carol A. Prescott, Ph.D.
Human Brain Metabolic Response to Caffeine and the Effects of Tolerance
Stephen R. Dager, M.D.; Matthew E. Layton, M.D., Ph.D.; Wayne Strauss, Ph.D.; Todd L. Richards, Ph.D.; Aaron Heide, M.D.; Seth D. Friedman, Ph.D.; Alan A. Artru, M.D.; Cecil E. Hayes, Ph.D.; Stefan Posse, Ph.D.
Striatal Dopaminergic Abnormalities in Human Cocaine Users
Karley Y. Little, M.D.; Lian Zhang, Ph.D.; Timothy Desmond, Ph.D.; Kirk A. Frey, M.D., Ph.D.; Gregory W. Dalack, M.D.; Bader J. Cassin, M.D.
Heritability of Anxiety Sensitivity: A Twin Study
Murray B. Stein, M.D.; Kerry L. Jang, Ph.D.; W. John Livesley, M.D., Ph.D.
Cerebral Blood Flow and Personality: A Positron Emission Tomography Study
Debra L. Johnson, Ph.D.; John S. Wiebe, M.A.; Sherri M. Gold, Ph.D.; Nancy C. Andreasen, M.D., Ph.D.; Richard D. Hichwa, Ph.D.; G. Leonard Watkins, Ph.D.; Laura L. Boles Ponto, Ph.D.
Revising and Assessing Axis II, Part I: Developing a Clinically and Empirically Valid Assessment Method
Drew Westen, Ph.D.; Jonathan Shedler, Ph.D.
Revising and Assessing Axis II, Part II: Toward an Empirically Based and Clinically Useful Classification of Personality Disorders
Drew Westen, Ph.D.; Jonathan Shedler, Ph.D.
Clinical and Theoretical Implications of 5-HT2 and D2 Receptor Occupancy of Clozapine, Risperidone, and Olanzapine in Schizophrenia
Shitij Kapur, M.D., Ph.D., F.R.C.P.C.; Robert B. Zipursky, M.D., F.R.C.P.C.; Gary Remington, M.D., Ph.D., F.R.C.P.C.
Clozapine and Risperidone in Chronic Schizophrenia: Effects on Symptoms, Parkinsonian Side Effects, and Neuroendocrine Response
Alan F. Breier, M.D.; Anil K. Malhotra, M.D.; Tung-Ping Su, M.D.; Debra A. Pinals, M.D.; Igor Elman, M.D.; Caleb M. Adler, M.D.; R. Todd Lafargue, M.D.; Allan Clifton, B.A.; David Pickar, M.D.
Diazepam Treatment of Early Signs of Exacerbation in Schizophrenia
William T. Carpenter, Jr., M.D.; Robert W. Buchanan, M.D.; Brian Kirkpatrick, M.D.; Alan F. Breier, M.D.
Clinical Case Conference
When Religion Collides With Medicine
Nada L. Stotland, M.D.
Brief Report
Incidence of Tardive Dyskinesia in Early Stages of Low-Dose Treatment With Typical Neuroleptics in Older Patients
Dilip V. Jeste, M.D.; Jonathan P. Lacro, Pharm.D.; Barton Palmer, Ph.D.; Enid Rockwell, M.D.; M. Jackuelyn Harris, M.D.; Michael P. Caligiuri, Ph.D.
Body Weight and Leptin Plasma Levels During Treatment With Antipsychotic Drugs
Thomas Kraus, M.D.; Monika Haack, M.A.; Andreas Schuld, M.D.; Dunja Hinze-Selch, M.D.; Martin K�hn, M.D.; Manfred Uhr, M.D.; Thomas Pollm�cher, M.D.
Prevalence of Depressive Symptoms Early in the Course of Schizophrenia
Thomas H. Wassink, M.D.; Michael Flaum, M.D.; Peg Nopoulos, M.D.; Nancy C. Andreasen, M.D., Ph.D.
B Lymphocyte Antigen D8/17 and Repetitive Behaviors in Autism
Eric Hollander, M.D.; Gina DelGiudice-Asch, M.D.; Lorraine Simon, M.A.; James Schmeidler, Ph.D.; Charles Cartwright, M.D.; Concetta M. DeCaria, Ph.D.; Jee Kwon, B.A.; Charlotte Cunningham-Rundles, M.D., Ph.D.; Floresta Chapman, R.N.; John B. Zabriskie, M.D.
Attitudes Toward DSM-IV Dissociative Disorders Diagnoses Among Board-Certified American Psychiatrists
Harrison G. Pope, Jr., M.D.; Paul S. Oliva, Ed.M.; James I. Hudson, M.D., S.M.; J. Alexander Bodkin, M.D.; Amanda J. Gruber, M.D.
Are Psychiatrists Cost-Effective? An Analysis of Integrated Versus Split Treatment
Mantosh Dewan, M.D.
Letter to the Editor
Risperidone for Exclusively Negative Symptoms
Hsien-Yuan Lane, M.D.; Chia-Chang Liu, M.D.; Wen-Ho Chang, M.D.
There Is Nothing New Under the Sun
DAN A. OREN, M.D.
Smoking Cessation and Anxiety
EVE J. WISEMAN, M.D.
Dr. West Replies
ROBERT WEST, PH.D.
Managed Care and Psychotherapy for Schizophrenia
HASSAN S. DINAKAR, M.D.; ROBERT N. SOBEL, M.D.
Mr. Hogarty Replies
GERARD E. HOGARTY, M.S.W.
Book Forum: WHO WE ARE AND WHAT WE DO
Freud vs. God: How Psychiatry Lost Its Soul and Christianity Lost Its Mind
PETER D. KRAMER, M.D.
Freud vs. God: How Psychiatry Lost Its Soul and Christianity Lost Its Mind
GEORGE E. VAILLANT, M.D.
Extraordinary Minds: Portraits of Exceptional Individuals and an Examination of Our Extraordinariness
ALAN A. STONE, M.D.
How Do We Know Who We Are? A Biography of the Self
SAXBY PRIDMORE, M.D.
The Eighties: A Reader
JAMES R. MERIKANGAS, M.D.
Book Forum: PSYCHODYNAMICS AND PSYCHOTHERAPY
How to Practice Brief Psychodynamic Psychotherapy: The Core Conflictual Relationship Theme Method
PAUL ROAZEN, PH.D.
Cognitive Psychodynamics: From Conflict to Character
WILLIAM A. FROSCH, M.D.
Freud and His Aphasia Book: Language and the Sources of Psychoanalysis
RICHARD M. WAUGAMAN, M.D.
Book Forum: Somatic Therapies
Handbook of Essential Psychopharmacology
ARTHUR RIFKIN, M.D.
The Practitioner’s Guide to Psychoactive Drugs, 4th ed.
BARRY LISKOW, M.D.
Melatonin in Psychiatric and Neoplastic Disorders
ERIC A. NOFZINGER, M.D.
Electroconvulsive Therapy: A Programmed Text, 2nd ed.
MAX FINK, M.D.
Book Forum: International Perspectives
New Research in Psychiatry
STEVEN S. SHARFSTEIN, M.D.
Clinical Methods in Transcultural Psychiatry
PEDRO RUIZ, M.D.
Images In Neuroscience
Brain Development, X: Pruning During Development
PHILIP SEEMAN, M.D., PH.D.
Images in Psychiatry
Juan J. Lopez Ibor, M.D., 1906–1991
PEDRO RUIZ, M.D.
  |  
Copyright ©
American
Psychiatric
Association